Product Description
Opioid addiction is a problem with high costs to individuals, families, and society. This TIP provides a detailed description of medication-assisted treatment for opioid addiction, including optional approaches such as comprehensive maintenance treatment, detoxification, and medically supervised withdrawal. SAMHSA (Substance Abuse and Mental Health Services Administration) recently released new guidelines on medication-assisted treatment in Opioid Treatment Programs (OTPs), which largely provide services to people addicted to heroin or prescription drugs containing opiates.
Targeted to treatment providers and administrators in OTPs, education-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs, SAMHSA’s Treatment Improvement Protocol 43 (TIP 43), provides updated information on effective treatment practices and care. The TIP emphasizes the importance of support services such as counseling, mental health, and related medical services, as well as vocational rehabilitation. TIP 43 consolidates and updates earlier TIPs on methadone treatment for opioid dependence. The new TIP also complements TIP 40, Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Currently, there are more than 1,100 OTPs operating in the United States. According to the guide, medication-assisted treatment offers a more comprehensive, individually tailored program than other types of treatment. Medication-assisted treatment includes pharmacotherapy integrated with psychosocial and medical treatment and support services. The guide emphasizes that opioid dependence is a treatable medical disorder. To support patients in recovery, TIP 43 highlights ways to combat the effects of stigma in communities.